Health Condition 1: K297- Gastritis, unspecified
Conditions
Interventions
None listed
Sponsors
National Institute of Ayurveda
Eligibility
Inclusion criteria
Inclusion criteria: Night workers of either sex Presence of Amlapitta as diagnosed by Amlapitta Symptom Rating Scale Score of 5 or more Participants willing to give written informed consent. Currently engaged in night shift work (Ratrojagaran will be considered 12 pm to 6am minimum of 3 months, more than 5 nights/month)
Exclusion criteria
Exclusion criteria: Pregnant or lactating women. Participants with documented H pylori infection. Participants with history of psychiatric disorders including eating disorders. Participants documented with chronic degenerative diseases including uncontrolled hepatic, renal or endocrine diseases (except diabetes controlled by oral hypoglycaemic agents or controlled hypothyroidism) malabsorption or chronic diarrhoea, history of seizures or epilepsy, gastric surgery or participants with oncological diseases. Participants with history of gastroesophageal surgery and surgery to reduce the secretion of gastric acid. Participants with history of oesophageal varix (varices) Participants with history of malignant neoplasm of gastrointestinal tract. Participants with history of thrombosis or administered with anti-thrombotic drugs. Participants administered with H2 receptor antagonists, muscarinic receptor antagonists, gastrin receptor antagonist, proton pump inhibitors, prostaglandins or mucosal protective agents prior to study in 1 weeks. Participants with history of Zollinger-Ellison syndrome Participants documented with auto-immune disease, uncontrolled hypertension, Diabetes mellitus requiring insulin injections and chronic severe respiratory disease. History of life threatening cardiovascular and /or neurological event in the past one year. Participants with history of drug abuse, bleeding disorder. Participants who cannot give valid consent such as mentally retarded, unconscious participants and psychiatric illness. Known history of positive screening result for hepatitis B and/or Hepatitis C virus. History of HIV or any immune deficient conditions. Participants on corticosteroid, sleep medication, antipsychotic drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the Amlapitta Symptom Rating Scale score compared to baselineTimepoint: 30 Days | — |
Secondary
| Measure | Time frame |
|---|---|
| Enhancing awareness of circadian health and Dosha management through Ayurvedic principles. Change in the PPDS symptom scale compared to baseline Change in the EPS symptom scale compared to baseline Change in the GERD scale compared to baseline Timepoint: 30 Days | — |
Countries
India
Contacts
Public ContactSuryawanshi Payal Prataprao
National Institute of Ayurveda
Outcome results
None listed